Articles dans des revues avec comité de lecture (257)

  1. 119. Sadeghi-Meibodi, N., Salmon, I., Decaestecker, C., Levivier, M., Metens, T., Wikler, D., Denolin, V., Rorive, S., Massager, N., Balériaux, D., & Goldman, S. (2007). Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. American journal of neuroradiology, 28(3), 455-461.
  2. 120. Decaestecker, C., Debeir, O., Van Ham, P., & Kiss, R. (2007). Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration. Medicinal research reviews, 27(2), 149-176. doi:10.1002/med.20078
  3. 121. Mijatovic, T., Gailly, P., Mathieu, V., De Nève, N., Yeaton, P., Kiss, R., & Decaestecker, C. (2007). Neurotensin is a versatile modulator of in vitro human pancreatic ductal adenocarcinoma cell (PDAC) migration. Cellular oncology, 29(4), 315-326.
  4. 122. Servotte, S., Camby, I., Debeir, O., Deroanne, C., Lambert, C. A., Lapière, C. M., Kiss, R., Nusgens, B., & Decaestecker, C. (2006). The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells. Neuropathology and applied neurobiology, 32(6), 575-584. doi:10.1111/j.1365-2990.2006.00760.x
  5. 123. Rorive, S., Maris, C., Debeir, O., Sandras, F., Vidaud, M., Bièche, I., Salmon, I., & Decaestecker, C. (2006). Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. Journal of neuropathology and experimental neurology, 65(8), 794-807. doi:10.1097/01.jnen.0000228203.12292.a1
  6. 124. Saussez, S., Cucu, D.-R., Decaestecker, C., Chevalier, D., Kaltner, H., André, S., Wacreniez, A., Toubeau, G., Camby, I., Gabius, H.-J., & Kiss, R. (2006). Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Annals of surgical oncology, 13(7), 999-1009. doi:10.1245/ASO.2006.08.033
  7. 125. Ghanooni, R., Decaestecker, C., Simon, P., Gabius, H.-J., Hassid, S., & Choufani, G. (2006). Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas. Hearing research, 214(1-2), 7-16. doi:10.1016/j.heares.2006.01.013
  8. 126. Hayot, C., Debeir, O., Van Ham, P., Van Damme, M., Kiss, R., & Decaestecker, C. (2006). Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicology and applied pharmacology, 211(1), 30-40. doi:10.1016/j.taap.2005.06.006
  9. 127. Daelemans, A., Leloup, T., Decaestecker, C., & De Mey, A. (2006). New digital method for quantitative assessment of nasal morphology. Scandinavian journal of plastic and reconstructive surgery and hand surgery, 40(6), 335-344. doi:10.1080/02844310601029837
  10. 128. Dubois, F., Yourassowsky, C., Monnom, O., Legros, J. C., Debeir, O., Van Ham, P., Kiss, R., & Decaestecker, C. (2006). Digital holographic microscopy for the three-dimensional dynamic analysis of in vitro cancer cell migration. Journal of biomedical optics, 11(5), 054032. doi:10.1117/1.2357174
  11. 129. Lefranc, F., Decaestecker, C., Brotchi, J., Heizmann, C. W., De Witte, O., Kiss, R., & Mijatovic, T. (2005). Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm. Neuropathology and applied neurobiology, 31(6), 649-660. doi:10.1111/j.1365-2990.2005.00682.x
  12. 130. Saal, I., Nagy, N., Lensch, M., Lohr, M., Manning, J. C., Decaestecker, C., André, S., Kiss, R., Salmon, I., & Gabius, H.-J. (2005). Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histology and histopathology, 20(4), 1191-1208.

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>